Items tagged with Latent TB
This guide is intended for primary care providers who care for patients who may be at risk for latent TB infection (LTBI) to progress to TB disease. Recommendations include: Treatment Regimens, Special Considerations in the Treatment of LTBI, Adverse Effects of Drugs Used to Treat LTBI, Patient Monitoring and Education During Treatment, Assessing Adherence, Techniques to Improve Adherence, and Post-Treatment Follow-Up. Most recent recommendations also include the use of interferon-gamma release assays (IGRAs).
Guidelines for Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis Infection (document)
CDC and American Thoracic Society releases new and updated recommendations for targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI).
Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC (document)
This document lays out general guidelines for effective prevention and control of TB in jails, prisons, and other correctional and detention facilities. Strategies for TB-prevention and -control in correctional facilities highlight the importance of early identification of TB through patient entry and periodic follow-up screening; successful treatment of TB disease and latent TB infection; appropriate use of airborne precautions (e.g., airborne infection isolation, environmental controls, and respiratory protection); comprehensive discharge planning; and thorough and efficient contact investigation.
Point-of-care diagnostics for tuberculosis elimination? (post with simple image)
The projected epidemiological effect of Xpert MTB/RIF might be overestimated, so this fascinating and promising new tool is unlikely to be the magic bullet that paves the way towards tuberculosis elimination.
CROI 2014: New drugs, novel combos top tuberculosis news at conference (post with simple image)
With increased TB activism and research into new treatments, preventive therapies, and diagnostics, the space devoted to TB at CROI has increased substantially.
WHO guidelines on the management of latent tuberculosis infection launched at the 45th Conference on Lung Health (post with simple image)
For the first time, the World Health Organization has issued guidelines on testing, treating and managing latent TB infection in individuals with high risk of developing disease.
Latent TB: Shorter course of therapy effective in children (post with simple image)
In children with latent tuberculosis, 3 months of combined therapy with isoniazid and rifapentine is safe and as effective as 9 months of isoniazid alone.
Stop TB Partnership staff get tested for TB: A call for universal access to TB testing (post with simple image)
12 March 2015 -- Geneva, Switzerland -- In an initiative to highlight that there should be no stigma associated with tuberculosis (TB) and that anyone could be infected with TB no matter where they live, the Stop TB Partnership Secretariat staff, colleagues from UNOPS and the Global Fund to Fight AIDS, Tuberculosis & Malaria are today getting tested through an interferon gamma release assay (test) that will determine if the person is infected with latent TB.
Open letter to WHO: Recording and reporting of preventive TB therapy in children (post with simple image)
Members of the global childhood TB community respond to the World Health Organization requesting additions to the End TB Strategy list of priority indicators related to the monitoring and evaluation of treatment for latent TB infection in children.
Intensifying action against latent tuberculosis infection (post with simple image)
If 8% of persons with latent tuberculosis could be permanently protected each year, the global TB incidence in 2050 would be 14 times lower as the incidence in 2013, with no other intervention needed.
Page 5 of 6 · Total posts: 0←First 4 5 6 Last→